Chengyun Dou

407 total citations
19 papers, 262 citations indexed

About

Chengyun Dou is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Chengyun Dou has authored 19 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Molecular Biology and 6 papers in Hepatology. Recurrent topics in Chengyun Dou's work include Liver Disease Diagnosis and Treatment (7 papers), Hepatitis B Virus Studies (5 papers) and Epigenetics and DNA Methylation (3 papers). Chengyun Dou is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Hepatitis B Virus Studies (5 papers) and Epigenetics and DNA Methylation (3 papers). Chengyun Dou collaborates with scholars based in China and United States. Chengyun Dou's co-authors include Kai Wang, Yu‐Chen Fan, Shuai Gao, Yang Yang, Leilei Huang, Jiayan Lian, Xia Xie, Zhuo Wang, Liantang Wang and Wenlin Xie and has published in prestigious journals such as Scientific Reports, Calcified Tissue International and Digestive Diseases and Sciences.

In The Last Decade

Chengyun Dou

16 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengyun Dou China 10 110 72 69 64 51 19 262
Palma Aurelia Iacovazzi Italy 12 124 1.1× 34 0.5× 64 0.9× 47 0.7× 57 1.1× 23 349
Haifeng Lin China 8 98 0.9× 70 1.0× 53 0.8× 50 0.8× 108 2.1× 32 303
Yasuhiko Nakao Japan 8 88 0.8× 48 0.7× 130 1.9× 60 0.9× 35 0.7× 31 262
Dayan Cao China 11 120 1.1× 29 0.4× 74 1.1× 37 0.6× 47 0.9× 18 319
Jörg‐Martin Bangen Germany 5 205 1.9× 47 0.7× 111 1.6× 89 1.4× 45 0.9× 6 365
Nicoletta Bertino Italy 6 89 0.8× 78 1.1× 128 1.9× 147 2.3× 64 1.3× 7 317
Lianqing Lou China 12 166 1.5× 127 1.8× 136 2.0× 103 1.6× 36 0.7× 22 361
Beatriz Lozano‐Ruiz Spain 10 164 1.5× 24 0.3× 71 1.0× 46 0.7× 85 1.7× 11 340
Can Gan China 10 167 1.5× 49 0.7× 168 2.4× 135 2.1× 55 1.1× 17 423

Countries citing papers authored by Chengyun Dou

Since Specialization
Citations

This map shows the geographic impact of Chengyun Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyun Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyun Dou more than expected).

Fields of papers citing papers by Chengyun Dou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyun Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyun Dou. The network helps show where Chengyun Dou may publish in the future.

Co-authorship network of co-authors of Chengyun Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyun Dou. A scholar is included among the top collaborators of Chengyun Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyun Dou. Chengyun Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Guo, Ruifeng, et al.. (2025). First insight into eosinophils as a biomarker for the early distinction of COVID-19 from influenza A in outpatients. Experimental and Therapeutic Medicine. 29(3). 56–56.
2.
3.
4.
5.
6.
Peng, Zhong, Hong Huang, Wenjun Ding, et al.. (2022). Microparticles from Hyperphosphatemia-Stimulated Endothelial Cells Promote Vascular Calcification Through Astrocyte-Elevated Gene-1. Calcified Tissue International. 111(1). 73–86. 9 indexed citations
7.
Dou, Chengyun, et al.. (2020). A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19. Diabetes Research and Clinical Practice. 166. 108300–108300. 19 indexed citations
8.
Xie, Xia, et al.. (2020). MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis. Digestive Diseases and Sciences. 66(6). 1928–1939. 14 indexed citations
9.
Dou, Chengyun, Jiayan Lian, Wen Zhou, et al.. (2018). Clinical outcomes and associated factors of radioiodine-131 treatment in differentiated thyroid cancer with cervical lymph node metastasis. Oncology Letters. 15(5). 8141–8148. 10 indexed citations
10.
Fan, Xiaopeng, et al.. (2017). Methylation status of the estrogen receptor 1 promoter predicts poor prognosis of acute-on-chronic hepatitis B liver failure. Revista Española de Enfermedades Digestivas. 110(12). 818–827. 4 indexed citations
11.
Dou, Chengyun, et al.. (2017). POEMS syndrome presentation with progressive weakness in upper and lower limbs: A case report. Oncology Letters. 14(5). 5197–5202. 1 indexed citations
12.
Dou, Chengyun, Zhuo Wang, Ruhua Zhang, et al.. (2016). EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity. Oncology Reports. 35(6). 3489–3495. 40 indexed citations
13.
Wang, Zhuo, Leilei Huang, Yuefeng Wang, et al.. (2016). Down-regulation of tumor endothelial marker 8 suppresses cell proliferation mediated by ERK1/2 activity. Scientific Reports. 6(1). 23419–23419. 10 indexed citations
14.
Dou, Chengyun, et al.. (2016). An unusual mediastinal parathyroid carcinoma coproducing PTH and PTHrP: A case report. Oncology Letters. 11(6). 4113–4116. 5 indexed citations
15.
Zhao, Zehua, Yu‐Chen Fan, Qi Zhao, et al.. (2015). Promoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failure. Clinical Epigenetics. 7(1). 115–115. 30 indexed citations
16.
Dou, Chengyun, et al.. (2015). Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma. Digestive Diseases and Sciences. 61(4). 1130–1138. 29 indexed citations
17.
Fan, Yu‐Chen, et al.. (2014). Aberrant DNA Methylation of G-protein-coupled Bile Acid Receptor Gpbar1 (TGR5) is a Potential Biomarker for Hepatitis B Virus Associated Hepatocellular Carcinoma. International Journal of Medical Sciences. 11(2). 164–171. 59 indexed citations
18.
Zhang, Jianjun, Yu‐Chen Fan, Zehua Zhao, et al.. (2014). Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatment. Cellular and Molecular Immunology. 11(4). 396–404. 11 indexed citations
19.
Yang, Yang, Yu‐Chen Fan, Shuai Gao, et al.. (2014). Methylated Cysteine Dioxygenase-1 Gene Promoter in the Serum Is a Potential Biomarker for Hepatitis B Virus-Related Hepatocellular Carcinoma. The Tohoku Journal of Experimental Medicine. 232(3). 187–194. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Palma Aurelia Iacovazzi Breakdown of academic impact, for papers by Haifeng Lin Breakdown of academic impact, for papers by Yasuhiko Nakao Breakdown of academic impact, for papers by Dayan Cao Breakdown of academic impact, for papers by Jörg‐Martin Bangen Breakdown of academic impact, for papers by Nicoletta Bertino Breakdown of academic impact, for papers by Lianqing Lou Breakdown of academic impact, for papers by Beatriz Lozano‐Ruiz Breakdown of academic impact, for papers by Can Gan
Rankless by CCL
2026